trending Market Intelligence /marketintelligence/en/news-insights/trending/7n2m4nefohfwwkzjphjzha2 content esgSubNav
In This List

Dipexium Pharmaceuticals names chief medical officer

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Dipexium Pharmaceuticals names chief medical officer

New York-based drugmaker Dipexium Pharmaceuticals Inc. appointed Efthymios Deliargyris as chief medical officer.

Deliargyris was previously the chief medical adviser of the company.

Dipexium Pharmaceuticals is a late-stage pharmaceutical company, engaging in the development and marketing of antibiotics in the U.S.